In human breast cancer cells, PARP1 was revealed to mediate PARylation of MORC2 in DNA damage sites following DDR (119), which stimulated the ATPase and chromatin remodeling activities of MORC2 and protected the cell from death. Here, MORC2 is linked to breast cancer.